Bio-Rad Laboratories, Inc. (BIO-B)


NYSE - NYSE Real Time Price. Currency in USD
161.06+0.13 (+0.08%)
At close: 3:36 PM EDT
People also watch:
BIOBF-AHEI-AJW-BGEF-B
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open160.93
Prev Close160.93
Bid161.10 x 100
Ask161.56 x 100
Day's Range161.06 - 161.06
52wk Range124.50 - 161.06
1y Target EstN/A
Market Cap4.74B
P/E Ratio (ttm)48.85
Beta0.00
Volume1,608
Avg Vol (3m)177
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube6 days ago

    ETF’s with exposure to Bio-Rad Laboratories, Inc. : September 20, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Bio-Rad Laboratories, Inc. Here are 5 ETF’s with the largest exposure to BIO.B-US. Comparing the performance and risk of Bio-Rad Laboratories, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Bio-Rad Laboratories, Inc. :BIO.B-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
    Capital Cubelast month

    Bio-Rad Laboratories, Inc. :BIO.B-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016

    Categories: Yahoo Finance Click here to see latest analysis Bio-Rad Laboratories, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Bio-Rad Laboratories, Inc. – PerkinElmer, Inc., Thermo Fisher Scientific Inc., Harvard Bioscience, Inc., Becton, Dickinson and Company, Cepheid, Danaher Corporation, Johnson & Johnson and General Electric ... Read more (Read more...)

  • Illumina and FlowJo, LLC Partner to Develop and Co-Market a Software Solution for Single Cell Genomics
    Business Wire2 months ago

    Illumina and FlowJo, LLC Partner to Develop and Co-Market a Software Solution for Single Cell Genomics

    Illumina, Inc. and FlowJo, LLC, today announced a partnership to develop and co-market analysis software for single cell next-generation sequencing data. Under the agreement FlowJo, LLC, the producer of FlowJo, market-leading software for single cell analysis, will develop a new software application.